Daniel Gooding

Title: Daniel Gooding: Innovator in Pharmaceutical Compositions

Introduction

Daniel Gooding is a notable inventor based in Great Britain, recognized for his contributions to the field of pharmaceutical compositions. He has developed innovative solutions aimed at treating various medical conditions, showcasing his expertise in the industry.

Latest Patents

Although Daniel Gooding currently holds no patents, his latest work includes significant advancements in the area of aprepitant L-proline solvate compositions and cocrystals. These compositions are designed to treat or prevent disorders related to emesis, neuropsychiatric diseases, inflammatory diseases, pain, cancer, skin diseases, respiratory diseases, and addictions. His formulations include a variety of compositions and cocrystals, such as a 1:1:1 aprepitant L-proline methanol composition and a 1:1:1 aprepitant L-proline H2O cocrystal, which may be used in conjunction with pharmaceutically acceptable carriers.

Career Highlights

Daniel Gooding is currently employed at Nuformix Technologies Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing compositions that enhance the efficacy of existing treatments, thereby improving patient outcomes.

Collaborations

Daniel collaborates with talented professionals in his field, including Joanne Holland and Christopher Frampton. Their combined expertise contributes to the advancement of pharmaceutical innovations at Nuformix Technologies Limited.

Conclusion

Daniel Gooding's work in pharmaceutical compositions demonstrates his commitment to improving healthcare solutions. His innovative approaches have the potential to significantly impact the treatment of various medical conditions.